These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 15374749)
1. Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation. Pontikis CC; Cella CV; Parihar N; Lim MJ; Chakrabarti S; Mitchison HM; Mobley WC; Rezaie P; Pearce DA; Cooper JD Brain Res; 2004 Oct; 1023(2):231-42. PubMed ID: 15374749 [TBL] [Abstract][Full Text] [Related]
2. Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons. Parviainen L; Dihanich S; Anderson GW; Wong AM; Brooks HR; Abeti R; Rezaie P; Lalli G; Pope S; Heales SJ; Mitchison HM; Williams BP; Cooper JD Acta Neuropathol Commun; 2017 Oct; 5(1):74. PubMed ID: 29041969 [TBL] [Abstract][Full Text] [Related]
3. Developmental impairments of select neurotransmitter systems in brains of Cln3(Deltaex7/8) knock-in mice, an animal model of juvenile neuronal ceroid lipofuscinosis. Herrmann P; Druckrey-Fiskaaen C; Kouznetsova E; Heinitz K; Bigl M; Cotman SL; Schliebs R J Neurosci Res; 2008 Jun; 86(8):1857-70. PubMed ID: 18265413 [TBL] [Abstract][Full Text] [Related]
4. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease). Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019 [TBL] [Abstract][Full Text] [Related]
5. Hippocampal pathology in the human neuronal ceroid-lipofuscinoses: distinct patterns of storage deposition, neurodegeneration and glial activation. Tyynelä J; Cooper JD; Khan MN; Shemilts SJ; Haltia M Brain Pathol; 2004 Oct; 14(4):349-57. PubMed ID: 15605981 [TBL] [Abstract][Full Text] [Related]
6. Behavioral assessment in mouse models of neuronal ceroid lipofuscinosis using a light-cued T-maze. Wendt KD; Lei B; Schachtman TR; Tullis GE; Ibe ME; Katz ML Behav Brain Res; 2005 Jun; 161(2):175-82. PubMed ID: 15885820 [TBL] [Abstract][Full Text] [Related]
7. Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7/8 knock-in mouse model of Batten disease. Pontikis CC; Cotman SL; MacDonald ME; Cooper JD Neurobiol Dis; 2005 Dec; 20(3):823-36. PubMed ID: 16006136 [TBL] [Abstract][Full Text] [Related]
8. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease. Chan CH; Ramirez-Montealegre D; Pearce DA Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480 [TBL] [Abstract][Full Text] [Related]
9. Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 mice. Kuronen M; Lehesjoki AE; Jalanko A; Cooper JD; Kopra O Neurobiol Dis; 2012 Sep; 47(3):444-57. PubMed ID: 22569358 [TBL] [Abstract][Full Text] [Related]
10. Altered gene expression in the eye of a mouse model for batten disease. Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100 [TBL] [Abstract][Full Text] [Related]
11. Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis. Bible E; Gupta P; Hofmann SL; Cooper JD Neurobiol Dis; 2004 Jul; 16(2):346-59. PubMed ID: 15193291 [TBL] [Abstract][Full Text] [Related]
12. Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspective. Kühl TG; Dihanich S; Wong AM; Cooper JD J Child Neurol; 2013 Sep; 28(9):1117-22. PubMed ID: 24014506 [TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]. Mitchison HM; Bernard DJ; Greene ND; Cooper JD; Junaid MA; Pullarkat RK; de Vos N; Breuning MH; Owens JW; Mobley WC; Gardiner RM; Lake BD; Taschner PE; Nussbaum RL Neurobiol Dis; 1999 Oct; 6(5):321-34. PubMed ID: 10527801 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of lysosomal acid phosphatase in CLN3-defective cells and mouse brain tissue. Pohl S; Mitchison HM; Kohlschütter A; van Diggelen O; Braulke T; Storch S J Neurochem; 2007 Dec; 103(6):2177-88. PubMed ID: 17868323 [TBL] [Abstract][Full Text] [Related]
15. A murine model for juvenile NCL: gene targeting of mouse Cln3. Greene ND; Bernard DL; Taschner PE; Lake BD; de Vos N; Breuning MH; Gardiner RM; Mole SE; Nussbaum RL; Mitchison HM Mol Genet Metab; 1999 Apr; 66(4):309-13. PubMed ID: 10191119 [TBL] [Abstract][Full Text] [Related]
16. Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6). Oswald MJ; Palmer DN; Kay GW; Shemilt SJ; Rezaie P; Cooper JD Neurobiol Dis; 2005 Oct; 20(1):49-63. PubMed ID: 16137566 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3). Aldrich A; Bosch ME; Fallet R; Odvody J; Burkovetskaya M; Rama Rao KV; Cooper JD; Drack AV; Kielian T Ann Neurol; 2016 Dec; 80(6):909-923. PubMed ID: 27804148 [TBL] [Abstract][Full Text] [Related]
18. Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis. Weimer JM; Benedict JW; Getty AL; Pontikis CC; Lim MJ; Cooper JD; Pearce DA Brain Res; 2009 Apr; 1266():93-107. PubMed ID: 19230832 [TBL] [Abstract][Full Text] [Related]
19. Partial correction of the CNS lysosomal storage defect in a mouse model of juvenile neuronal ceroid lipofuscinosis by neonatal CNS administration of an adeno-associated virus serotype rh.10 vector expressing the human CLN3 gene. Sondhi D; Scott EC; Chen A; Hackett NR; Wong AM; Kubiak A; Nelvagal HR; Pearse Y; Cotman SL; Cooper JD; Crystal RG Hum Gene Ther; 2014 Mar; 25(3):223-39. PubMed ID: 24372003 [TBL] [Abstract][Full Text] [Related]
20. Moving towards therapies for juvenile Batten disease? Cooper JD Exp Neurol; 2008 Jun; 211(2):329-31. PubMed ID: 18400221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]